Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons

被引:236
|
作者
SklairTavron, L
Shi, WX
Lane, SB
Harris, HW
Bunney, BS
Nestler, EJ
机构
[1] YALE UNIV,SCH MED,DEPT PSYCHIAT,LAB MOL PSYCHIAT,NEW HAVEN,CT 06508
[2] YALE UNIV,SCH MED,DEPT PHARMACOL,LAB MOL PSYCHIAT,NEW HAVEN,CT 06508
[3] CONNECTICUT MENTAL HLTH CTR,NEW HAVEN,CT 06508
关键词
opiate addiction; brain-derived neurotrophic factor; tyrosine hydroxylase; lucifer yellow; mesolimbic dopamine system;
D O I
10.1073/pnas.93.20.11202
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mesolimbic dopamine system, which arises in the ventral tegmental area (VTA), is an important neural substrate for opiate reinforcement and addiction, Chronic exposure to opiates is known to produce biochemical adaptations in this brain region, We now show that these adaptations are associated with structural changes in VTA dopamine neurons, Individual VTA neurons in paraformaldehyde-fixed brain sections from control or morphine-treated rats were injected with the fluorescent dye Lucifer yellow, The identity of the injected cells as dopaminergic or nondopaminergic was determined by immunohistochemical labeling of the sections for tyrosine hydroxylase, Chronic morphine treatment resulted in a mean approximate to 25% reduction in the area and perimeter of VTA dopamine neurons, This reduction in cell size was prevented by concomitant treatment of rats with naltrexone, an opioid receptor antagonist, as well as by intra-VTA infusion of brain-derived neurotrophic factor, In contrast, chronic morphine treatment did not alter the size of nondopaminergic neurons in the VTA, nor did it affect the total number of dopaminergic neurons in this brain region, The results of these studies provide direct evidence for structural alterations in VTA dopamine neurons as a consequence of chronic opiate exposure, which could contribute to changes in mesolimbic dopamine function associated with addiction.
引用
收藏
页码:11202 / 11207
页数:6
相关论文
共 50 条
  • [1] LONG-LASTING CHANGES IN MORPHINE-INDUCED MESOLIMBIC DOPAMINE RELEASE AFTER CHRONIC MORPHINE EXPOSURE
    SPANAGEL, R
    ALMEIDA, OFX
    SHIPPENBERG, TS
    [J]. SYNAPSE, 1993, 14 (03) : 243 - 245
  • [2] IDENTIFIED POSTNATAL MESOLIMBIC DOPAMINE NEURONS IN CULTURE - MORPHOLOGY AND ELECTROPHYSIOLOGY
    RAYPORT, S
    SULZER, D
    SHI, WX
    SAWASDIKOSOL, S
    MONACO, J
    BATSON, D
    RAJENDRAN, G
    [J]. JOURNAL OF NEUROSCIENCE, 1992, 12 (11): : 4264 - 4280
  • [3] EFFECTS OF LESION OF MESOLIMBIC DOPAMINE NEURONS ON PAIN THRESHOLD AND MORPHINE ANALGESIA IN RATS
    SZRENIAWSKI, Z
    MESZAROS, J
    GAJEWSKA, S
    TARCHALSKAKRYNSKA, B
    [J]. POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1977, 29 (05): : 521 - 525
  • [4] Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons
    Melis, M
    Diana, M
    Gessa, GL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) : R1 - R3
  • [5] Regulation of phospholipase Cγ in the mesolimbic dopamine system by chronic morphine administration
    Wolf, DH
    Numan, S
    Nestler, EJ
    Russell, DS
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) : 1520 - 1528
  • [6] CHRONIC MORPHINE IMPAIRS AXOPLASMIC-TRANSPORT IN THE RAT MESOLIMBIC DOPAMINE SYSTEM
    BEITNERJOHNSON, D
    NESTLER, EJ
    [J]. NEUROREPORT, 1993, 5 (01) : 57 - 60
  • [7] Inhibition of Morphine- and Ethanol-Mediated Stimulation of Mesolimbic Dopamine Neurons by Withania somnifera
    Bassareo, Valentina
    Talani, Giuseppe
    Frau, Roberto
    Porru, Simona
    Rosas, Michela
    Kasture, Sanjay B.
    Peana, Alessandra T.
    Loi, Eleonora
    Sanna, Enrico
    Acquas, Elio
    [J]. FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [8] Chronic hyperprolactinemia and changes in dopamine neurons
    Mohankumar, PS
    Mohankumar, SMJ
    Kaleem, S
    Quadri, SK
    Voogt, JL
    [J]. BRAIN RESEARCH BULLETIN, 1997, 42 (06) : 435 - 441
  • [9] Mesostriatal, mesolimbic and mesocortical dopamine neurons in primates
    Williams, SM
    GoldmanRakic, PS
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 445 - 445